• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨 Paget 病。

Paget's disease of bone.

机构信息

Center for Bone Quality, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):657-668. doi: 10.1016/j.beem.2018.05.005. Epub 2018 May 26.

DOI:10.1016/j.beem.2018.05.005
PMID:30449547
Abstract

Paget's disease of bone is a focal disorder of bone remodelling that progresses slowly and leads to changes in the shape and size of affected bones and to skeletal, articular and vascular complications. In some parts of the world it is the second most common bone disorder after osteoporosis though in recent years its prevalence and severity appear to decrease. The disease is easily diagnosed and effectively treated but its pathogenesis remains incompletely understood.

摘要

佩吉特病是一种骨重建的局灶性疾病,其进展缓慢,导致受累骨骼的形状和大小发生变化,并引起骨骼、关节和血管并发症。在世界某些地区,它是继骨质疏松症之后第二常见的骨骼疾病,但近年来其患病率和严重程度似乎有所下降。该病易于诊断且治疗效果显著,但发病机制仍不完全清楚。

相似文献

1
Paget's disease of bone.骨 Paget 病。
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):657-668. doi: 10.1016/j.beem.2018.05.005. Epub 2018 May 26.
2
[Paget's disease of bone: Diagnostic and therapeutic updates].[骨佩吉特病:诊断与治疗的最新进展]
Rev Med Interne. 2018 Mar;39(3):185-191. doi: 10.1016/j.revmed.2017.05.010. Epub 2017 Jul 6.
3
Pathogenesis of Paget's disease of bone.骨佩吉特病的发病机制。
Bone. 2008 Nov;43(5):819-25. doi: 10.1016/j.bone.2008.06.015. Epub 2008 Jul 11.
4
Paget's disease: current concepts.佩吉特病:当前概念
Aust N Z J Surg. 1992 Jan;62(1):17-23. doi: 10.1111/j.1445-2197.1992.tb05349.x.
5
Paget's disease of bone: clinical review and update.骨 Paget 病:临床综述与更新。
J Clin Pathol. 2013 Nov;66(11):924-7. doi: 10.1136/jclinpath-2013-201688. Epub 2013 Sep 16.
6
[What is Paget's disease?].[什么是佩吉特病?]
Rev Prat. 1989 Apr 27;39(13):1104-8.
7
Paget's disease of bone with particular reference to dentistry.骨佩吉特病,特别涉及牙科领域
J Oral Pathol. 1981 Aug;10(4):233-47. doi: 10.1111/j.1600-0714.1981.tb01270.x.
8
Etiology of Paget's disease and osteoclast abnormalities.佩吉特病的病因及破骨细胞异常
J Cell Biochem. 2004 Nov 1;93(4):688-96. doi: 10.1002/jcb.20256.
9
Paget's disease of bone: clinical, pathogenetic and therapeutic aspects.骨佩吉特病:临床、发病机制及治疗方面
Baillieres Clin Endocrinol Metab. 1997 Apr;11(1):117-43. doi: 10.1016/s0950-351x(97)80553-8.
10
Paget's disease of bone.骨佩吉特病
Handb Clin Neurol. 2014;119:529-40. doi: 10.1016/B978-0-7020-4086-3.00034-5.

引用本文的文献

1
An emerging role of mitochondrial quality control in bone metabolism: from molecular mechanisms to targeted therapeutic interventions.线粒体质量控制在骨代谢中的新作用:从分子机制到靶向治疗干预
Cell Mol Life Sci. 2025 Jul 29;82(1):291. doi: 10.1007/s00018-025-05802-w.
2
Latest Advances in Structural Insights and Quantification Techniques for Type I Collagen Biomarkers: A path toward standardization?I型胶原蛋白生物标志物的结构见解与定量技术的最新进展:迈向标准化之路?
Biomark Insights. 2025 May 24;20:11772719251336274. doi: 10.1177/11772719251336274. eCollection 2025.
3
Distinct features of three clinical subtypes in 533 patients with primary hypertrophic osteoarthropathy.
533例原发性肥大性骨关节病患者三种临床亚型的不同特征。
Orphanet J Rare Dis. 2025 Apr 18;20(1):188. doi: 10.1186/s13023-025-03722-3.
4
Optineurin Cooperates With NRF2 to Regulate Tooth Root Morphogenesis by Controlling Mitochondrial Dynamics and Apoptosis.视紫质神经元相互作用蛋白(Optineurin)与核因子E2相关因子2(NRF2)协同作用,通过控制线粒体动力学和细胞凋亡来调节牙根形态发生。
Cell Prolif. 2025 May;58(5):e13799. doi: 10.1111/cpr.13799. Epub 2025 Jan 6.
5
Stage-specific modulation of multinucleation, fusion, and resorption by the long non-coding RNA DLEU1 and miR-16 in human primary osteoclasts.长链非编码 RNA DLEU1 和 miR-16 对人原代破骨细胞多核化、融合和吸收的阶段特异性调节。
Cell Death Dis. 2024 Oct 11;15(10):741. doi: 10.1038/s41419-024-06983-1.
6
Immune-related osteoblastic bone alterations mimicking bone metastasis in a small-cell lung cancer patient treated with durvalumab: a case report.度伐利尤单抗治疗的小细胞肺癌患者中出现类似骨转移的免疫相关成骨性骨改变:一例报告
Transl Lung Cancer Res. 2024 Aug 31;13(8):2043-2049. doi: 10.21037/tlcr-24-461. Epub 2024 Aug 17.
7
Paget's Disease of Bone: A Rare Incidence in Early Adult Life in Pakistan, Southeast Asia.骨佩吉特病:在巴基斯坦、东南亚地区的成年早期发病率较低。
Cureus. 2023 Dec 9;15(12):e50242. doi: 10.7759/cureus.50242. eCollection 2023 Dec.
8
Metabolic bone disorders and the promise of marine osteoactive compounds.代谢性骨病与海洋活性化合物的前景。
Cell Mol Life Sci. 2023 Dec 20;81(1):11. doi: 10.1007/s00018-023-05033-x.
9
Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis.用动力学-药效学模型和暴露-反应分析优化唑来膦酸的给药方案。
Front Pharmacol. 2023 Sep 27;14:1089774. doi: 10.3389/fphar.2023.1089774. eCollection 2023.
10
Optineurin regulates osteoblast function in an age-dependent fashion in a mouse model of Paget's disease of bone.视黄醇结合蛋白 4 调节肥胖小鼠脂肪组织胰岛素抵抗和胰岛β细胞功能障碍。
Bone. 2023 Dec;177:116929. doi: 10.1016/j.bone.2023.116929. Epub 2023 Oct 5.